Coldstream Capital Management Inc. Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Coldstream Capital Management Inc. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 26.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 11,561 shares of the medical equipment provider's stock after purchasing an additional 2,399 shares during the period. Coldstream Capital Management Inc.'s holdings in Intuitive Surgical were worth $5,773,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical during the second quarter worth about $26,000. Godsey & Gibb Inc. raised its position in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after purchasing an additional 35 shares during the last quarter. LGT Financial Advisors LLC raised its position in Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock worth $30,000 after purchasing an additional 54 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the 3rd quarter worth $33,000. Finally, Mark Sheptoff Financial Planning LLC bought a new position in Intuitive Surgical during the 2nd quarter worth $37,000. Institutional investors own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ISRG. Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price objective for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Mizuho boosted their target price on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Royal Bank of Canada boosted their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an "outperform" rating in a research report on Friday, October 18th. Stifel Nicolaus lifted their price target on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, December 5th. Finally, Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Tuesday, November 19th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $541.33.

Insider Buying and Selling

In other news, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the transaction, the director now owns 821 shares in the company, valued at $402,519.88. This trade represents a 35.41 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Mark Brosius sold 2,115 shares of the firm's stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the sale, the insider now owns 295 shares in the company, valued at $145,113.45. The trade was a 87.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,485 shares of company stock worth $26,128,102. 0.90% of the stock is owned by insiders.

Intuitive Surgical Stock Down 0.1 %

Shares of NASDAQ ISRG traded down $0.77 on Tuesday, reaching $538.09. 1,047,243 shares of the company's stock traded hands, compared to its average volume of 1,443,882. Intuitive Surgical, Inc. has a 12 month low of $309.80 and a 12 month high of $556.23. The business's 50 day simple moving average is $517.16 and its two-hundred day simple moving average is $475.65. The company has a market cap of $191.66 billion, a price-to-earnings ratio of 86.51, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.